The Role of Natural Antibodies to CC Chemokine Receptor 5 in HIV Infection
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Natural Antibodies to CC Chemokine Receptor 5 in HIV Infection
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-10-30
DOI
10.3389/fimmu.2017.01358
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study
- (2017) SL Pett et al. HIV MEDICINE
- Host controls of HIV broadly neutralizing antibody development
- (2017) Garnett Kelsoe et al. IMMUNOLOGICAL REVIEWS
- The quest for an antibody-based HIV vaccine
- (2017) Barton F. Haynes et al. IMMUNOLOGICAL REVIEWS
- Survivors Remorse: antibody-mediated protection against HIV-1
- (2017) George K. Lewis et al. IMMUNOLOGICAL REVIEWS
- HIV antibodies for treatment of HIV infection
- (2017) David M. Margolis et al. IMMUNOLOGICAL REVIEWS
- Specification of implementation interventions to address the cascade of HIV care and treatment in resource-limited settings: a systematic review
- (2017) Matthew D. Hickey et al. Implementation Science
- Design of HIV Coreceptor Derived Peptides That Inhibit Viral Entry at Submicromolar Concentrations
- (2017) Kostyantyn D. Bobyk et al. MOLECULAR PHARMACEUTICS
- Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells
- (2017) Malika Hale et al. MOLECULAR THERAPY
- Immunochemical engineering of cell surfaces to generate virus resistance
- (2017) Jia Xie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expanding HIV testing and linkage to care in southwestern Uganda with community health extension workers
- (2017) Stephen Asiimwe et al. Journal of the International AIDS Society
- Driving HIV-1 into a Vulnerable Corner by Taking Advantage of Viral Adaptation and Evolution
- (2017) Shigeyoshi Harada et al. Frontiers in Microbiology
- The Membrane-Proximal Region of C–C Chemokine Receptor Type 5 Participates in the Infection of HIV-1
- (2017) Yue Tan et al. Frontiers in Immunology
- CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV
- (2016) Michelle B. Kim et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Ubiquitin-Related Roles of β-Arrestins in Endocytic Trafficking and Signal Transduction
- (2016) Pierre-Yves Jean-Charles et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Class B β-arrestin2-dependent CCR5 signalosome retention with natural antibodies to CCR5
- (2016) Assunta Venuti et al. Scientific Reports
- Efficient Modification of the CCR5 Locus in Primary Human T Cells With megaTAL Nuclease Establishes HIV-1 Resistance
- (2016) Guillermo S Romano Ibarra et al. Molecular Therapy-Nucleic Acids
- ERK1-Based Pathway as a New Selective Mechanism To Modulate CCR5 with Natural Antibodies
- (2015) Assunta Venuti et al. JOURNAL OF IMMUNOLOGY
- CCR5 susceptibility to ligand-mediated down-modulation differs between human T lymphocytes and myeloid cells
- (2015) James M. Fox et al. JOURNAL OF LEUKOCYTE BIOLOGY
- AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges
- (2015) Matthew R. Gardner et al. NATURE
- mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5
- (2015) U. Mock et al. NUCLEIC ACIDS RESEARCH
- Maraviroc – A CCR5 Antagonist for the Treatment of HIV-1 Infection
- (2015) Elna Van Der Ryst Frontiers in Immunology
- A Linear Epitope in the N-Terminal Domain of CCR5 and Its Interaction with Antibody
- (2015) Benny Chain et al. PLoS One
- Potent Anti-HIV Chemokine Analogs Direct Post-Endocytic Sorting of CCR5
- (2015) Claudia Bönsch et al. PLoS One
- The potential to target CCL5/CCR5 in breast cancer
- (2014) Marco Velasco-Velázquez et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Natural Antibodies Bridge Innate and Adaptive Immunity
- (2014) Saswati Panda et al. JOURNAL OF IMMUNOLOGY
- Induction of HIV-Blocking Anti-CCR5 IgA in Peyers's Patches without Histopathological Alterations
- (2014) C. Pastori et al. JOURNAL OF VIROLOGY
- Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
- (2014) Pablo Tebas et al. NEW ENGLAND JOURNAL OF MEDICINE
- TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity
- (2014) Claudio Mussolino et al. NUCLEIC ACIDS RESEARCH
- Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection
- (2014) Lin Ye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inflammation-related factors predicting prognosis of gastric cancer
- (2014) Wen-Jun Chang WORLD JOURNAL OF GASTROENTEROLOGY
- Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection
- (2013) C. A. Didigu et al. BLOOD
- Clinical development of monoclonal antibody-based drugs in HIV and HCV diseases
- (2013) Michela Flego et al. BMC Medicine
- A Vaccine against CCR5 Protects a Subset of Macaques upon Intravaginal Challenge with Simian Immunodeficiency Virus SIVmac251
- (2013) K. K. A. Van Rompay et al. JOURNAL OF VIROLOGY
- Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
- (2013) Seung Woo Cho et al. NATURE BIOTECHNOLOGY
- CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity
- (2013) Thomas J. Cradick et al. NUCLEIC ACIDS RESEARCH
- A Nonparametric Procedure for Defining a New Humoral Immunologic Profile in a Pilot Study on HIV Infected Patients
- (2013) Chiara Brombin et al. PLoS One
- Newer Gene Editing Technologies toward HIV Gene Therapy
- (2013) N. Manjunath et al. Viruses-Basel
- Is the CCR5 Δ 32 Mutation Associated with Immune System-Related Diseases?
- (2012) Khodayar Ghorban et al. INFLAMMATION
- Peptides from Second Extracellular Loop of C-C Chemokine Receptor Type 5 (CCR5) Inhibit Diverse Strains of HIV-1
- (2012) Cajetan Dogo-Isonagie et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MARCH2 promotes endocytosis and lysosomal sorting of carvedilol-bound β2-adrenergic receptors
- (2012) Sang-oh Han et al. JOURNAL OF CELL BIOLOGY
- Agonist-directed Interactions with Specific β-Arrestins Determine μ-Opioid Receptor Trafficking, Ubiquitination, and Dephosphorylation
- (2011) Chad E. Groer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Natural anti-CCR5 antibodies in HIV-infection and -exposure
- (2011) Lucia Lopalco Journal of Translational Medicine
- Silencing or Stimulation? siRNA Delivery and the Immune System
- (2011) Kathryn A. Whitehead et al. Annual Review of Chemical and Biomolecular Engineering
- Phase 2a Study of the CCR5 Monoclonal Antibody PRO 140 Administered Intravenously to HIV-Infected Adults
- (2010) J. M. Jacobson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evidence for the cure of HIV infection by CCR5 32/ 32 stem cell transplantation
- (2010) K. Allers et al. BLOOD
- CC Chemokine Receptor 5 (CCR5) Desensitization
- (2010) Jean-Michel Escola et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epitope Mapping of Ibalizumab, a Humanized Anti-CD4 Monoclonal Antibody with Anti-HIV-1 Activity in Infected Patients
- (2010) R. Song et al. JOURNAL OF VIROLOGY
- CCR5: From Natural Resistance to a New Anti-HIV Strategy
- (2010) Lucia Lopalco Viruses-Basel
- CCR5 antagonism in HIV infection: ways, effects, and side effects
- (2009) Pierre Corbeau et al. AIDS
- Hepatitis C virus cell entry: role of lipoproteins and cellular receptors
- (2009) M. E. Burlone et al. JOURNAL OF GENERAL VIROLOGY
- Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell Transplantation
- (2009) Gero Hütter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Monoclonal antibody-based therapies for microbial diseases
- (2009) Carolyn Saylor et al. VACCINE
- CCR5 monoclonal antibodies for HIV-1 therapy
- (2009) William C Olson et al. Current Opinion in HIV and AIDS
- Infection of Macrophages and Dendritic Cells with Primary R5-Tropic Human Immunodeficiency Virus Type 1 Inhibited by Natural Polyreactive Anti-CCR5 Antibodies Purified from Cervicovaginal Secretions
- (2008) J. Eslahpazir et al. Clinical and Vaccine Immunology
- A Deletion in the Chemokine Receptor 5(CCR5)Gene Is Associated with Tickborne Encephalitis
- (2008) Elin Kindberg et al. JOURNAL OF INFECTIOUS DISEASES
- Immunogenic Display of Diverse Peptides on Virus-like Particles of RNA Phage MS2
- (2008) David S. Peabody et al. JOURNAL OF MOLECULAR BIOLOGY
- Two Amino Acid Substitutions within the First External Loop of CCR5 Induce Human Immunodeficiency Virus-Blocking Antibodies in Mice and Chickens
- (2008) C. Pastori et al. JOURNAL OF VIROLOGY
- Highly potent, fully recombinant anti-HIV chemokines: Reengineering a low-cost microbicide
- (2008) H. Gaertner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nature and functions of autoantibodies
- (2008) Keith Elkon et al. Nature clinical practice. Rheumatology
- Regulation of GPCRs by Endocytic Membrane Trafficking and Its Potential Implications
- (2007) Aylin C. Hanyaloglu et al. Annual Review of Pharmacology and Toxicology
- G Protein–Coupled Receptor Sorting to Endosomes and Lysosomes
- (2007) Adriano Marchese et al. Annual Review of Pharmacology and Toxicology
- Targeting Chemokine Receptors in HIV: A Status Report
- (2007) Shawn E. Kuhmann et al. Annual Review of Pharmacology and Toxicology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started